Madrigal Pharmaceuticals, Inc.

MDGL stock score: 45/100

$457.96 · -2.05% · Scored Oct 21, 2026

Technical
51
Fundamental
38
News
54

The reading

Madrigal Pharmaceuticals (MDGL) scores 45 out of 100, which reads weak, higher than 47% of Healthcare stocks and 29% of the 4,166 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 51, fundamentals 38.

Among the fundamentals, Price Target at 100 and Fund Ownership at 100 score highest, while Earnings Quality (Annual) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 30 and contrarian oscillators 73 — a split worth reading before trusting the technical total.

News sentiment is neutral at 54; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 42 to 70, and it is down 25 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward MDGL’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

38

Pulling it up

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Fund Ownership100

    Fund ownership tracks institutional investor holdings and changes.

  • Revenue Growth (Annual)100

    Annual revenue growth tracks year-over-year sales expansion.

Holding it back

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

  • Price to Book Ratio0

    Price-to-Book ratio compares market value to book value.

  • Return on Equity (ROE)0

    Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.

38 weighted scorers; 3 had no data today and are left out rather than counted as zero.

Technical · daily

34

Pulling it up

  • Money Flow Index (14)98

    Money Flow Index (14-period) is a volume-weighted RSI that identifies overbought and oversold conditions.

  • Bollinger Bands (50)96

    Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

  • RSI (14)93

    Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.

Holding it back

  • Candlestick Patterns0

    Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Ichimoku Cloud0

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • TRIX0

    TRIX is a momentum oscillator that filters out short-term noise by triple-smoothing price data.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
54

Technical score by timeframe

ChartScoreWeight
Hourly491
Daily343
Weekly482
Monthly642
Quarterly692

Composite score, last 90 days

05010045Jul 25, 2026Oct 21, 2026Jul 25, 2026: 70Jul 26, 2026: 70Jul 27, 2026: 70Jul 28, 2026: 69Jul 29, 2026: 70Jul 30, 2026: 66Jul 31, 2026: 66Aug 2, 2026: 51Aug 3, 2026: 53Aug 5, 2026: 55Aug 6, 2026: 54Aug 7, 2026: 52Aug 8, 2026: 52Aug 9, 2026: 52Aug 10, 2026: 53Aug 11, 2026: 55Aug 12, 2026: 56Aug 13, 2026: 52Aug 14, 2026: 50Aug 15, 2026: 50Aug 16, 2026: 50Aug 17, 2026: 54Aug 18, 2026: 54Aug 19, 2026: 55Aug 20, 2026: 54Aug 22, 2026: 50Aug 23, 2026: 50Aug 24, 2026: 48Aug 25, 2026: 48Aug 26, 2026: 52Aug 27, 2026: 53Aug 28, 2026: 52Aug 29, 2026: 53Aug 30, 2026: 53Aug 31, 2026: 52Sep 1, 2026: 53Sep 2, 2026: 53Sep 3, 2026: 53Sep 4, 2026: 52Sep 5, 2026: 52Sep 6, 2026: 52Sep 7, 2026: 52Sep 8, 2026: 52Sep 9, 2026: 52Sep 10, 2026: 50Sep 11, 2026: 51Sep 12, 2026: 51Sep 13, 2026: 51Sep 14, 2026: 52Sep 15, 2026: 49Sep 16, 2026: 49Sep 17, 2026: 51Sep 18, 2026: 50Sep 19, 2026: 51Sep 20, 2026: 51Sep 21, 2026: 49Sep 22, 2026: 49Sep 23, 2026: 50Sep 24, 2026: 49Sep 25, 2026: 48Sep 26, 2026: 48Sep 27, 2026: 48Sep 28, 2026: 48Sep 29, 2026: 46Sep 30, 2026: 46Oct 1, 2026: 45Oct 2, 2026: 46Oct 3, 2026: 46Oct 4, 2026: 46Oct 5, 2026: 45Oct 6, 2026: 46Oct 7, 2026: 45Oct 8, 2026: 44Oct 9, 2026: 43Oct 10, 2026: 44Oct 11, 2026: 44Oct 12, 2026: 43Oct 13, 2026: 42Oct 14, 2026: 43Oct 15, 2026: 43Oct 16, 2026: 42Oct 17, 2026: 42Oct 18, 2026: 42Oct 19, 2026: 42Oct 20, 2026: 45Oct 21, 2026: 45
Show the daily numbers
DateComposite
Oct 21, 202645
Oct 20, 202645
Oct 19, 202642
Oct 18, 202642
Oct 17, 202642
Oct 16, 202642
Oct 15, 202643
Oct 14, 202643
Oct 13, 202642
Oct 12, 202643
Oct 11, 202644
Oct 10, 202644
Oct 9, 202643
Oct 8, 202644
Oct 7, 202645
Oct 6, 202646
Oct 5, 202645
Oct 4, 202646
Oct 3, 202646
Oct 2, 202646
Oct 1, 202645
Sep 30, 202646
Sep 29, 202646
Sep 28, 202648
Sep 27, 202648
Sep 26, 202648
Sep 25, 202648
Sep 24, 202649
Sep 23, 202650
Sep 22, 202649
Sep 21, 202649
Sep 20, 202651
Sep 19, 202651
Sep 18, 202650
Sep 17, 202651
Sep 16, 202649
Sep 15, 202649
Sep 14, 202652
Sep 13, 202651
Sep 12, 202651
Sep 11, 202651
Sep 10, 202650
Sep 9, 202652
Sep 8, 202652
Sep 7, 202652
Sep 6, 202652
Sep 5, 202652
Sep 4, 202652
Sep 3, 202653
Sep 2, 202653
Sep 1, 202653
Aug 31, 202652
Aug 30, 202653
Aug 29, 202653
Aug 28, 202652
Aug 27, 202653
Aug 26, 202652
Aug 25, 202648
Aug 24, 202648
Aug 23, 202650
Aug 22, 202650
Aug 20, 202654
Aug 19, 202655
Aug 18, 202654
Aug 17, 202654
Aug 16, 202650
Aug 15, 202650
Aug 14, 202650
Aug 13, 202652
Aug 12, 202656
Aug 11, 202655
Aug 10, 202653
Aug 9, 202652
Aug 8, 202652
Aug 7, 202652
Aug 6, 202654
Aug 5, 202655
Aug 3, 202653
Aug 2, 202651
Jul 31, 202666
Jul 30, 202666
Jul 29, 202670
Jul 28, 202669
Jul 27, 202670
Jul 26, 202670
Jul 25, 202670

Key facts

Market cap
$10.6B
Sector
Healthcare
Industry
Biotechnology
Beta
-1.05
Risk grade (1–10)
5
Next earnings
Nov 3, 2026

Biotechnology peers

CompanyMarket capScore
TECH Bio-Techne$11.4B59
BMRN BioMarin Pharmaceutical$10.7B46
PCVX Vaxcyte$10.0B48
TWST Twist Bioscience$9.9B52
KRYS Krystal Biotech$9.5B66
KYMR Kymera Therapeutics$9.3B52

Questions

What is MDGL's stock score today?

MDGL scores 45/100 (Weak) as of Oct 21, 2026: technical 51, fundamental 38, and news sentiment 54, which is shown but not counted. Scores are recomputed every night.

Is MDGL a buy?

The score is not a buy or sell recommendation. A 45 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the MDGL score calculated?

100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.